Evidence of positive selection at codon sites localized in extracellular domains of mammalian CC motif chemokine receptor proteins

BMC Evolutionary Biology

Volumn 10, Issue 1, 2010, Pages

  Metzger, Kelsey J ^a,b   Thomas, Michael A ^a  

^a Nucl Eng Idaho State University   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOCHEMISTRY; CHROMOSOME; CYTOLOGY; DATA SET; EVOLUTIONARY BIOLOGY; GENE EXPRESSION; HYPOTHESIS TESTING; IMMUNE SYSTEM; MAMMAL; NUCLEIC ACID; PATHOGEN; PHYLOGENETICS; PROTEIN; SOFTWARE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

CHEMOKINE RECEPTOR CCR;

ANIMAL; ARTICLE; CHEMISTRY; CODON; GENETIC SELECTION; GENETICS; HUMAN; IMMUNOLOGY;

ANIMALS; CODON; HUMANS; RECEPTORS, CCR; SELECTION, GENETIC;

EID: 77951954408     PISSN: None     EISSN: 14712148     Source Type: Journal    
DOI: 10.1186/1471-2148-10-139     Document Type: Article

References (62)

1. Chemokines, a family of chemotactic cytokines. DT Graves Y Jiang, Crit Rev Oral Biol Med 1995 6 109 118 10.1177/10454411950060020101 7548618
2. The chemokine system - a major regulator of angiogenesis in health and disease. MM Rosenkilde TW Schwartz, APMIS 2004 112 481 495 10.1111/j.1600-0463. 2004.apm11207-0808.x 15563311
3. Why chemokines are cytokines while their receptors are not cytokine ones? LB Goncharova AO Tarakanov, Curr Med Chem 2008 15 1297 1304 10.2174/092986708784535009 18537609
4. Structure, function, and inhibition of chemokines. EJ Fernandez E Lolis, Annu Rev Pharmacol Toxicol 2002 42 469 499 10.1146/annurev.pharmtox.42.091901. 115838 11807180
5. Chemokines and chemokine receptors: an overview. R Bonecchi E Galliera EM Borroni MM Corsi M Locati A Mantovani, Front Biosci 2009 14 540 551 10.2741/3261 19273084
6. Human chemokines: An update. M Baggiolini B Dewald B Moser, Annu Rev Immunol 1997 15 675 705 10.1146/annurev.immunol.15.1.675 9143704
7. High-resolution solution structure of the beta-chemokine HMIP-1-beta by multidimensional NMR. PJ Lodi DS Garrett J Kuszewski ML Tsang JA Weatherbee WJ Leonard AM Gronenborn GM Clore, Science 1994 263 1762 1767 10.1126/science. 8134838 8134838
8. The biology of chemokines and their receptors. D Rossi A Zlotnik, Annu Rev Immunol 2000 18 217 242 10.1146/annurev.immunol.18.1.217 10837058
9. Profiling heparin-chemokine interactions using synthetic tools. JL de Paz EA Moseman C Noti L Polito UH von Andrian PH Seeberger, ACS Chem Biol 2007 2 735 744 10.1021/cb700159m 18030990
10. Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. M Carrington M Dean MP Martin SJ O'Brien, Hum Mol Genet 1999 8 1939 1945 10.1093/hmg/8.10.1939 10469847
11. CCR5: No longer a 'good for nothing' gene - chemokine control of West Nile Virus infection. JK Lim WG Glass DH McDermott PM Murphy, Trends Immunol 2006 27 308 312 10.1016/j.it.2006.05.007 16753343
12. CCR5 saves lives: the protective role of CCR5 during West Nile virus infection. WG Glass JK Lim DH McDermott A Pletnev R Cholera J Gao S Lekhong SF Yu WA Frank J Pape RC Cheshier PM Murphy, J Neurochem 2006 96 94 94
13. CCR5 deficiency increases risk of symptomatic West Nile virus infection. WG Glass DH McDermott JK Lim S Lekhong SF Yu WA Frank J Pape RC Cheshier PM Murphy, J Exp Med 2006 203 35 40 10.1084/jem.20051970 16418398
14. Polymorphisms in CCL2 and CCL5 chemokines/chemokine receptors genes and their association with diseases. Z Navratilova, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006 150 191 204 17426779
15. Understanding the immunoangiostatic CXC chemokine network. ML Balestrieri A Balestrieri FP Mancini C Napoli, Cardiovasc Res 2008 78 250 256 10.1093/cvr/cvn029 18252760
16. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile Virus infection: A meta-analysis of 4 cohorts in the US epidemic. JK Lim CY Louie C Glaser C Jean B Johnson H Johnson DH McDermott PM Murphy, J Infect Dis 2008 197 262 265 10.1086/524691 18179388
17. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA - Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and Simian immunodeficiency virus. S Mummidi M Bamshad SS Ahuja E Gonzalez PM Feuillet K Begum MC Galvis V Kostecki AJ Valente KK Murthy L Haro MJ Dolan JS Allan SK Ahuja, J Biol Chem 2000 275 18946 18961 10.1074/jbc.M000169200 10747879
18. Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis. R Nadif M Mintz S Rivas-Fuentes A Jedlicka E Lavergne M Rodero F Kauffmann C Combadiere SR Kleeberger, Cytokine 2006 33 171 178 10.1016/j.cyto.2006.01.001 16524739
19. CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. G Alkhatib C Combadiere CC Broder Y Feng PE Kennedy PM Murphy EA Berger, Science 1996 272 1955 1958 10.1126/science.272.5270.1955 8658171
20. Chemokine receptors and HIV. CC Broder RG Collman, J Leukocyte Biol 1997 62 20 29 9225988
21. A receptor for the malarial parasite Plasmodium vivax - the erythrocyte chemokine receptor. R Horuk CE Chitnis WC Darbonne TJ Colby A Rybicki TJ Hadley LH Miller, Science 1993 261 1182 1184 10.1126/science.7689250 7689250
22. Viral hijacking of human receptors through heterodimerization. HF Vischer S Nijmeijer MJ Smit R Leurs, Biochem and Biophys Res Commun 2008 377 93 97 10.1016/j.bbrc.2008.09.082
23. Molecular piracy of chemokine receptors by herepesviruses. PM Murphy, Infect Agents Dis Rev Issues Comment 1994 3 137 154
24. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function. OMZ Howard AK Shirakawa JA Turpin A Maynard GJ Tobin M Carrington JJ Oppenheim M Dean, J Biol Chem 1999 274 16228 16234 10.1074/jbc.274.23.16228 10347178
25. Prevalence of chemokine and chemokine receptor polymorphisms in seroprevalent children with symptomatic HIV-1 infection in the United States. KK Singh CF Barroga MD Hughes J Chen C Raskino RE McKinney SA Spector, J Acquir Immune Defic Syndr 2004 35 309 313 10.1097/00126334-200403010-00013 15076247
26. Cytokine and chemokine gene polymorphisms among ethnically diverse North Americans with HIV-1 infection. CB Wang W Song E Lobashevsky CM Wilson SD Douglas J Mytilineos EE Schoenbaum JM Tang RA Kaslow, J Acquir Immune Defic Syndr 2004 35 446 454 10.1097/00126334-200404150-00002 15021309
27. Distribution of CCR2 polymorphism in HIV-1-infected and healthy subjects in North India. G Kaur P Singh N Kumar CC Rapthap G Sharma M Vajpayee N Wig SK Sharma NK Mehra, Int J Immunogenet 2007 34 153 156 10.1111/j.1744-313X.2007. 00667.x 17504503
28. Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India. P Suresh A Wanchu RK Sachdeva A Bhatnagar, J Clin Immunol 2007 27 131 131 10.1007/s10875-006-9054-y (Pubitemid 46224940)
29. Functional analysis of naturally occurring mutations in the open reading frame of CCR5 in HIV-infected Chinese patients and healthy controls. WY Zhao SS Lee KH Wong KCW Chan T Ng CCS Chan D Han WC Yam KY Yuen MH Ng BJ Zheng, J Acquir Immune Defic Syndr 2005 38 509 517 10.1097/01.qai.0000151004.19128.4a 15793360
30. Structure and function of CC-chemokine receptor 5 homologues derived from representative primate species and subspecies of the taxonomic suborders Prosimii and Anthropoidea. KJ Kunstman B Puffer BT Korber C Kuiken UR Smith J Kunstman J Stanton M Agy R Shibata AD Yoder S Pillai RW Doms P Marx SM Wolinsky, J Virol 2003 77 12310 12318 10.1128/JVI.77.22.12310-12318.2003 14581567
31. Gene conversion among chemokine receptors. DC Shields, Gene 2000 246 239 245 10.1016/S0378-1119(00)00072-X 10767545
32. Balancing selection. PW Hedrick, Curr Biol 2007 17 230 R231 10.1016/j.cub.2007.01.012 17407748
33. PAML: a program package for phylogenetic analysis by maximum likelihood. Z Yang, Comput Appl BioSci 1997 13 555 556 9367129
34. PAML 4: Phylogenetic Analysis by Maximum Likelihood. Z Yang, Mol Biol Evol 2007 24 1586 1591 10.1093/molbev/msm088 17483113
35. Bayes empirical Bayes inference of amino acid sites under positive selection. ZH Yang WSW Wong R Nielsen, Mol Biol Evol 2005 22 1107 1118 10.1093/molbev/msi097 15689528
36. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1 alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation. JE Pease J Wang PD Ponath PM Murphy, J Biol Chem 1998 273 19972 19976 10.1074/jbc.273.32.19972 9685332
37. Role of the first extracellular loop in the functional activation of CCR2 - The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling. KH Han SR Green RK Tangirala S Tanaka O Quehenberger, J Biol Chem 1999 274 32055 32062 10.1074/jbc.274.45.32055 10542238
38. Identification of the extracellular loop 2 as the point of interaction between the n terminus of the chemokine MIP-1 alpha and its CCR1 receptor. S Zoffmann A Chollet JL Galzi, Mol Pharmacol 2002 62 729 736 10.1124/mol.62.3.729 12181451
39. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. C Blanpain BJ Doranz A Bondue C Govaerts A De Leener G Vassart RW Doms A Proudfoot M Parmentier, J Biol Chem 2003 278 5179 5187 10.1074/jbc.M205684200 12466283
40. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner. I Sabroe A Jorritsma VEL Stubbs G Xanthou LA Jopling PD Panath TJ Williams PM Murphy JE Pease, Eur J Immunol 2005 35 1301 1310 10.1002/eji.200425171 15739168
41. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines. UE Duchesnes PM Murphy TJ Williams JE Pease, Mol Immunol 2006 43 1221 1231 10.1016/j.molimm.2005.07.015 16102831
42. Structural basis of chemokine receptor function - A model for binding affinity and ligand selectivity. L Rajagopalan K Rajarathnam, Biosci Rep 2006 26 325 339 10.1007/s10540-006-9025-9 17024562
43. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. JMR Frade M Llorente M Mellado J Alcami JC GutierrezRamos A Zaballos G delReal AC Martinez, J Clin Invest 1997 100 497 502 10.1172/JCI119558 9239395
44. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies. SQ Liu SX Fan ZR Sun, J Mol Modeling 2003 9 329 336 10.1007/s00894-003-0154-9 (Pubitemid 38097539)
45. Multiple residues in the extracellular domains of CCR3 are critical for coreceptor activity. PT Ho BE Teal TM Ross, Virology 2004 329 109 118 10.1016/j.virol.2004.07.028 15476879
46. nd extracellular domain by gene conversion with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species. CR Carmo PJ Esteves N Ferrand W van der Loo, Immunogenetics 2006 58 494 501 10.1007/s00251-006-0095-4 16596402
47. Extensive gene conversion between CCR2 and CCR5 in domestic cat (Felis catus). PJ Esteves J Abrantes W van der Loo, Int J Immunogenet 2007 34 321 324 10.1111/j.1744-313X.2007.00716.x 17845301
48. Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes: A potential mechanism for receptor dimerization. N Vazquez-Salat N Yuhki T Beck SJ O'Brien WJ Murphy, Genomics 2007 90 213 224 10.1016/j.ygeno.2007.04.009 17544254
49. Converted evolution of vertebrate CCR2 and CCR5 genes and the origin of a recombinant equine CCR5/2 gene. AA Perelygin AA Zharkikh NM Astakhova TL Lear MA Brinton, J Hered 2008 99 500 511 10.1093/jhered/esn029 18502735
50. A shared unusual genetic change at the chemokine receptor type 5 between Oryctolagus, Bunolagus and Pentalagus. J Abrantes CR Carmo CA Matthee F Yamada W van der Loo PJ Esteves, Conserv Genet 2009 DOI 10.1007/s10592-009-9990-1.
51. Gene Conversion Among Paralogs Results in Moderate False Detection of Positive Selection Using Likelihood Methods. C Casola MW Hahn, J Mol Evol 2009 68 679 687 10.1007/s00239-009-9241-6 19471989
52. National Center for Biotechnology Information Entrez Gene. http://www.ncbi.nlm.nih.gov/gene
53. The adequacy of morphology for reconstructing the early history of placental mammals. MS Springer A Burk-Herrick R Meredith E Eizirik E Teeling SJ O'Brien WJ Murphy, Syst Biol 2007 56 673 684 10.1080/10635150701491149 17661234
54. TimeTree:: The Timescale of Life. http://www.timetree.org
55. TimeTree: a public knowledge-base of divergence times among organisms. SB Hedges J Dudley S Kumar, Bioinformatics 2006 22 2971 2972 10.1093/ bioinformatics/btl505 17021158
56. On the best evolutionary rate for phylogenetic analysis. ZH Yang, Syst Biol 1998 47 125 133 10.1080/106351598261067 12064232
57. Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. M Anisimova JP Bielawski ZH Yang, Mol Biol Evol 2001 18 1585 1592 11470850
58. Maximum likelihood methods for detecting adaptive evolution after gene duplication. JP Bielawski ZH Yang, J Struct Funct Genomics 2003 3 201 212 10.1023/A:1022642807731 12836699
59. EMBOSS: The European Molecular Biology Open Software Suite. P Rice I Longden A Bleasby, Trends Genet 2000 16 276 277 10.1016/S0168-9525(00)02024-2 10827456
60. Modeltest: testing the model of DNA substitution. D Posada KA Crandall, Bioinformatics 1998 14 817 818 10.1093/bioinformatics/14.9.817 9918953
61. DL Swofford, PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4 Sinauer Associates, Sunderland, MA 2002
62. Building protein diagrams on the web with the residue-based diagram editor RdBe. L Skrabanek F Campagne H Weinstein, Nucleic Acids Res 2003 31 3856 3858 10.1093/nar/gkg552 12824436